Use of anti-obesity medications or AOMs and the associated demand for protein rich foods is a global trend set to benefit ...

A federal judge has blocked US President Donald Trump’s attempt to end birthright citizenship, and shares in the leading ...

Oprah Winfrey opens up on her podcast about her weight-loss journey with anti-obesity GLP-1 medications while chatting with doctors and guests. Plus, the media icon shares how her opinion of "thin ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new drug last month and ...

The rise in popularity of anti-obesity medications (AOMs), such as popular brand names Ozempic and Wegovy could see a shift ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Getting skinny on weight loss meds takes a fat wad of cash. And Staci Rice is working double-time for the petite payoffs.

The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...

The Trump administration inherited some big health policy headaches on Monday. And the nature of federal rules means it can't ...

"There was an increased risk of gastrointestinal disorders, hypotension, syncope (low blood pressure), arthritic disorders, ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...